Deadline for Receipt of Ballot:  11:59 pm U.S. Eastern Time, August 18, 2017

Biographical Sketches of Nominees

  • Click on each name to view the nominee's biographical information. Nominees are listed alphabetically by last name.
  • Scroll down to view biographical information for all nominees.

 

President

Leslie G. Biesecker, MD

Leslie G. Biesecker, MD

Senior Investigator and Chief of the Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health, 2014-present; Director, Physician-Scientist Development Program, NHGRI, NIH, 2002-present; Adjunct Associate Professor, Johns Hopkins University Bloomberg School of Public Health, 2002-present.

Education: BS with honors, Biochemistry, University of California, Riverside, 1979; MD, University of Illinois College of Medicine, 1983; Pediatric Residency, University of Wisconsin, 1983-1986, Genetics Fellowship, University of Michigan, 1988-1993.

Career summary prior to present position: Senior Investigator and Chief of the Genetic Disease Research Branch, NHGRI, NIH, 2006-2014; Tenured Senior Investigator, NHGRI, NIH 2001-present; Tenure Track Investigator, NHGRI, NIH, 1993-2001; Staff Pediatrician People’s Clinic and St. Louis Children’s Hospital, 1986-1988.

Honors and Awards: Best Teacher Award, University of Wisconsin Medical School Class of 1986; Outstanding Young Investigator, University of Michigan, Department of Pediatrics, 1992; NIH Director’s Award for developing the DNA testing brochure for World Trade Center victim families, 2002; NIH Director’s Award for serving on the Hurricane Katrina victim DNA identification panel, 2006; March of Dimes Pruzansky Award, 2014; NIH Director’s Award for supporting the HeLa Whole Genome Data Support Group, 2014; Elected to the National Academy of Medicine, 2016.

Government and Public Service: NIH National Institute of General Medical Sciences Committee on Informed Consent for the Human Mutant Cell Repository, 1995-1996; David Smith Meeting Organizing Committee, 1999; Co-Chair, NIH-Department of Energy IRB Guidebook Revision Committee, 2002-2004; Co-Chair, International Working Group on Dysmorphologic Terminology, 2005; Founding Member, International Cytogenomic Standard Array Working Group, 2009-2012; Co-Chair, American College Medical Genetics Working Group on Standards for Return of Results from Clinical Genome Sequencing Tests, 2011-2012; Panel Member, Evaluation of the NHANES genetic research return of results, National Academy of Sciences 2014; Co-Chair, ClinGen Sequence Variant Interpretation Standards Working Group, 2015; ACMG Subcommittee on Implications of Sharing Clinical Data & Phenotypic Information, 2016-present.  

Editorial Boards (alphabetical order): American Journal of Medical Genetics, BMC Medicine, Clinical Dysmorphology, Cold Spring Harbor Molecular Case Studies, Human Genome Variation.

Research Interests: Molecular Genetic Etiology, Natural History, and Therapeutic Approaches for Proteus Syndrome, PIK3CA-related Overgrowth Spectrum, Penttinen Syndrome, Pallister-Hall Syndrome, McKusick-Kaufman Syndrome, and Lenz Microphthamia Syndrome. Predictive genomic medicine for adult-onset disorders including cancer susceptibility, cardiac disease, and malignant hyperthermia.

Prior Service to ASHG: Committee on Informed Consent for Stored Specimens, 1998; ASHG Annual Meeting Abstract Reviewer, 2002, 2005; MD/PhD Annual Meeting Travel Award Selection Committee, 2004; Program Committee, 2005-2008; Chair, Program Committee, 2009; Board of Directors, 2011-2013; Strategic Planning Committee, 2013-2014; Editorial Board, American Journal of Human Genetics, 2013-2016; Chair, Future of the Annual Meeting Committee, 2014-2015.

Directors (vote for three) (listed alphabetically by last name)

Katrina A.B. Goddard, PhD

Senior Investigator, Center for Health Research, Kaiser Permanente Northwest, 2007-present; Affiliate Associate Professor, Department of Molecular and Medical Genetics, Oregon Health & Sciences University, 2008-present.

Education: BS with honors, Molecular Biology, University of Wisconsin-Madison, Madison, WI, 1990; MS, Biostatistics, University of Washington School of Public Health, Seattle, WA, 1995; PhD, Biostatistics, University of Washington School of Public Health, Seattle, WA, 1999.

Career summary prior to present position: Assistant Professor, Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, 1999-2005; Associate Professor, Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, 2005-2007; Mid-career Fellow in Genetics and Public Health Research and Practice, Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, GA, 2006-2007.

Government and Public Service: Chair, Clinical Sequencing Exploratory Research Consortium, National Human Genome Research Institute, 2015-2016; External Advisory Panel, IGNITE Consortium, National Human Genome Research Institute, 2014-2017; Board of Directors, International Genetic Epidemiology Society, 2010-2013; Member, Oregon Legislative Advisory Committee on Genetic Privacy & Research, 2009-2011; Chair, Ethical, Legal, and Social Issues Committee, International Genetic Epidemiology Society, 2006-2010; Member, Scientific Program Committee, International Genetic Epidemiology Society, 2006-2009; Ad hoc Review Panel Member, Center for Scientific Review, National Institutes of Health, 2002-present.

Editorial Boards: Genetic Epidemiology, PLOS Currents: Evidence on Genomic Tests, Proceedings of the Genetic Analysis Workshop.

Research Interests: Genetic Epidemiology, Public Health Genomics, Evidence Synthesis, Translational Research on Genomic Applications, Hereditary Cancer Syndromes, Population Screening.

Prior Service to ASHG: ASHG Annual Meeting Abstract Reviewer, 2015; Reviewer, American Journal of Human Genetics.

 


Peng Jin, PhD

Professor, Department of Human Genetics, Emory University School of Medicine, 2013-present; Vice Chair, Department of Human Genetics, Emory University School of Medicine, 2016-present.

Education: BS, Molecular Biology, University of Science and Technology of China, 1994; PhD, Molecular and Developmental Biology, University of Cincinnati College of Medicine, Cincinnati, OH, 1999; Postdoctoral Fellow, Howard Hughes Medical Institute, Emory University School of Medicine, Atlanta, GA, 1999-2004.

Career summary prior to present position: Assistant Professor, Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, 2004-2010; Associate Professor, Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, 2010-2013.

Honors and Awards: Finalists for Outstanding Postdoctoral Research Award in the American Society of Human Genetics, 2000, 2003; Beckman Young Investigator Award, 2005; Basil O'Connor Scholar Research Award, 2006; Alfred P. Sloan Research Fellow, 2006; NARSAD Independent Investigator Award, 2013; Suzanne and John Golden Investigator, 2014; Changjiang (Yangtze River) Scholar, Ministry of Education, China, 2016.

Government and Public Service: Chair, Trans NIH Fragile X Research Coordinating Group, FXTAS, 2007, 2012; Board Member, Association of Chinese Geneticists in America, 2008-present; President, Organizers of Keystone Meetings, Winter Conference on Brain Research and Other International Conferences, 2015-2017; Arnold O. Beckman Foundation Review Committee, 2015-present; Numerous reviews for NIH (CSR, NIMH, NICHD, NINDS, NIEHS and NIA), CDC, DOD, VA, and National Ataxia Foundation; Member, RNA Mechanism in Cancer Study Section, American Cancer Society; Reviews for Wellcome Trust, UK MRC, Hong Kong, Netherlands Genomics Initiative, National Science Foundation of China, Israel Science Foundation New Zealand HRC.

Editorial Boards (alphabetical order): Frontiers in Neurogenesis, Frontiers in Non-coding RNAs, Journal of Genetics and Genomics, PLoS Genetics.

Research Interests: Human Genetics and Epigenetics, Neuroepigenetics, Noncoding RNAs, Genetic Determinants of Neurodevelopmental and Neurodegenerative Disorders, Unstable Repeat Sequence Mutations, Animal Models of Human Diseases; Treatment of Genetic Disorders, Autism, Fragile X Syndrome, Fragile X Tremor Ataxia Syndrome, Fragile X-associated Primary Ovarian Insufficiency, Toxic RNA Disorders.

Prior Service to ASHG: Organizer of ASHG Annual Meeting Invited Sessions, 2006, 2007, 2008, and 2010; Judge, ASHG Annual DNA Essay Contest, 2009-2017; Session Moderator, ASHG Annual Meeting, 2011-2016; ASHG Annual Meeting Abstract Reviewer, 2011-2016.

 


Donna M. Martin, MD, PhD

Donita B. Sullivan Research Professor of Pediatrics and Communicable Diseases, Professor of Pediatrics and Communicable Diseases, 2011-present; Director and Service Chief, Division of Genetics, Metabolism, and Genomic Medicine, Department of Pediatrics, 2016-present; Associate Director, Medical Scientist Training Program, 2012-present.

Education: BS summa cum laude, Mathematics and Foreign Language, Michigan Technological University, Houghton, MI, 1987; PhD, Neuroscience, University of Michigan, Ann Arbor, MI, 1992; MD, University of Michigan Medical School, Ann Arbor, MI, 1996; Internship and Residency, Pediatrics, Mott Children’s Hospital, University of Michigan, Ann Arbor, MI, 1997-1999; Medical Genetics Residency and Postdoctoral Research, University of Michigan, Ann Arbor, MI, 1999-2001.

Career summary prior to present position: Lecturer, Pediatrics and Communicable Diseases, Division of Genetics, Research Investigator in Human Genetics, University of Michigan Medical School 2001-2003; Assistant Professor, Pediatrics and Communicable Diseases, Division of Genetics, and in Human Genetics, University of Michigan Medical School, 2003-2008; Associate Professor, Pediatrics and Communicable Diseases (with tenure), Division of Genetics, Metabolism and Genomic Medicine, and Associate Professor of Human Genetics, University of Michigan 2008-2015; Associate Director, Medical Scientist Training Program, University of Michigan Medical School, 2012-present; Professor of Pediatrics and Professor of Human Genetics, University of Michigan, 2015-present; Director, Division of Genetics, Metabolism and Genomic Medicine, University of Michigan, 2016-present.

Honors and Awards: Janette Ferrantino Award, 2003; Best Doctors in America (Detroit Hour Magazine), 2007, 2012; Top Resident Teacher Award, Department of Pediatrics, 2010; American Society for Clinical Investigation (ASCI) (elected), 2011; University of Michigan Medical School League of Research Excellence Award, 2015; Special Recognition Award, CHARGE Syndrome Foundation, 2015; Rudi Ansbacher Women in Academic Medicine Leadership Scholar, 2017; University of Michigan Medical School Candidate for Executive Leadership in Academic Medicine (ELAM) Fellowship, 2017. 

Government and Public Service: ASCI Councilor, 2017-present; Chair, CHARGE Syndrome Foundation Scientific Advisory Board, 2012-present; NIH Developmental Brain Disorders (DBD) Study Section, 2009-2015; International Rett Syndrome Foundation Scientific Review Board, 2008; ClinGen Peds Neuro Working Group, 2016-present; Simons Foundation Powering Autism Research for Knowledge (SPARK) Medical Genetics Committee, 2017-present; Michigan Department of Community Health (MDCH) BioTrust Scientific Advisory Board, 2013-present; Numerous ad hoc reviews for NIH (DBD, NCF, BDCN, MDCN, NDPR, ZRG, CTSA); Reviewer for NSF, State of Pennsylvania Department of Health, Oak Ridge Associated Universities, Medical Research Council (UK), Israel Science Foundation, Wellcome Trust (UK), Italian Telethon. 

Editorial Boards (alphabetical order): American Journal of Medical Genetics, Molecular and Cellular Neurosciences.   

Research Interests: CHARGE Syndrome, Genetic Determinants of Neurodevelopmental Disorders and Autism Spectrum Disorder, Human Genetics and Genomics, X-linked Disorders, Hearing Loss and Craniofacial Malformations, Mouse Models of Human Disease, Chromatin Accessibility, Transcriptional Regulation of Neuronal Development and Neurogenesis in the Brain. 

Prior Service to ASHG: Session Chair at annual meeting (several); ASHG Annual Meeting Abstract Reviewer, 2016, 2017; Organizer of Invited Session on CHARGE syndrome, ASHG Annual Meeting, 2009.

 


Andres Metspalu, MD, PhD

Professor, Biotechnology, Institute of Cell and Molecular Biology, University of Tartu, 1992-present; Director, Estonian Genome Center, University of Tartu, 2007-present.

Education: MD, University of Tartu, Tartu, Estonia, 1976; PhD, Tartu University, 1979. (PhD thesis was defended in Institute of Molecular Genetics, Ukrainian Acad. of Sciences, Kiev, Ukraine); Postdoc, Columbia University, New York (IREX fellow, Prof. Alex Tzagaloff lab), 1981; Postdoc, Prof. Joan A. Steitz Laboratory, Yale University, New Haven, 1982.

Career summary prior to present position: Specialist and Junior Scientist, University of Tartu, Estonia (1976-1982); Senior Scientist, Laboratory of Molecular Biology, University of Tartu, 1982-1985; Head of Laboratory of Gene Expression, University of Tartu, 1985-1992; Research Director, Estonian Biocentre, Tartu, 1986-1992; Professor, Biotechnology, University of Tartu, 1992; Sabbatical leave, Professor (visiting), Molecular and Human Genetics, Baylor College of Medicine and C.T. Caskey Laboratory, Houston, TX, 1993-1994; Head of Molecular Diagnostics Centre at Tartu University Clinics, Tartu, 1996-2007; WHO International Agency for Research of Cancer (IARC), Lyon, France, The Visiting Scientist Award, 2000 (12 months); Founder and Member, Managing Board of the Estonian Genome Center, Tartu, Estonia, 2000-2007; Sabbatical leave, University of Lausanne, CIG, 2012 (3 months).

Honors and Awards: Soviet Estonian Prize for Science, 1980; Person of the Year (Loop), 1999; 3rd Class Order of the Estonian Red Cross, 2001; Prix de la Garantie Medicale et Chirurgicale, France, 2002; Estonian Science Award in Medicine, 2003; L'Ordre des Palmes Académiques, Chevalier, France, 2003; President of the European Society of Human Genetics, 2005-2006; Member of the ScanBalt Academy 2005; Vilnius University Dr. H. C., 2010; Elected Member of the Estonian Academy of Sciences, 2010; Honorary Citizen of Tartu, 2014; Tartu University “Grand Medal”, 2016.

Government and Public Service: Member, Expert Council of Soviet Union Human Genome program, 1988-1990; Member, Bioethics Council of the Ministry of Social Affairs of Republic of Estonia, 1998-2002; Program Committee, International Congress of Genetics, Brisbane, Australia, 1998-2002; Member, American Society of Human Genetics, 1995-present; Member, Human Genome Organization (HUGO), 1995; Member, Scientific Council of the IMCB of University of Tartu, 1996-present; Founding Head of Molecular Diagnostics Centre at Tartu University Hospital (established the DNA diagnostics and new born screening in Estonia),1996-2007; Expert, French Ministry of Research and Ministry of Social Affairs, France, 2001-2017; The Wellcome Trust, UK Central and East European Fellowship Program, 2002-2004; Expert, Helmholtz Society, Germany, 2000; Member, Estonian Research Council, 1997-2000, and 2003-2009; Board Member, SPC Member, European Society of Human Genetics as a board member and SPC member, 2000 –2010, and Executive Board Member, 2005-2007; Board of Directors, P3G Consortium Montreal, Canada, 2003-2007, and 2015-present; Member, Steering Committee, European Science Foundation Functional Genomics Program, 2001-2011; Member, International Advisory Board, Biotechnology Centre of Excellence, Vilnius, Lithuania, 2003-2006; Member, Scientific Council of the Institute of Technology, University of Tartu, 2006-2007; Veterinary and Food Board of the Estonian Government, Member of the Expert group for GMO- and Innovated Foods, 2007-2011; Chairman, Netherlands Genomics Initiative of Centre for Medical Systems Biology Site-Visit, 2011; Member, EU ESFRI BMS, Estonian Ministry of Research and Education, 2008-2013; Expert Panel, European Research Council, Brussels, 2010-2016; Board Member, University of Tartu, 2012-2016; Member, EU BBMRI-ERIC Management Committee, and Director, Estonian Biobanking Node, 2013-present; Member, EU Science Europe Scientific Advisory Committee, Brussels, 2014-present; Chair, Program Committee, Euroscience Open Forum (ESOF 2018), Toulouse, France, 2015-2018.

Editorial Boards (alphabetical order): Clinical Genetics, Heredity Cancer in Clinical Practice.

Research Interests: My main scientific interests have developed over many years starting from the ribosome structure to human genetics, array technology development and application to genetics of rare and complex diseases, GWAS analysis and biobanking. I wrote and co-authored more than 360 papers and chapters in international peer review journals and books. My h-index is 72. My main contributions are on the field of microarrays (APEX), human genetics and genomics, GWAS studies of common complex disease and population based biobanks (The Estonian Genome Center of University of Tartu, www.biobank.ee).

In Estonia, I proposed the idea of the Estonian Biobank in 2000 and just now we finished genotyping the whole biobank of 52,500 people and will start to give, according to the HGR Act, the feedback to the people who wish to know (carrier status, incidental findings (ACMG list)), pharmacogenomics (few CYP450 LoF cases) and disease risks for common diseases (like T2D, CAD and few more) from September 2017. These are all new activities and I do hope that integrating the genomics research, electronic medical care data allow to maximize advances in understanding, prevention and therapy of the diseases. In addition, in 2014 I convinced the Estonian Health Care Insurance Fund to cover the exome sequencing as a diagnostic procedure for the rare diseases and from 2015 the Estonian Genome Center NGS core sequenced the trios for the Tartu University Hospital and now hospital lab can do it itself and from 2017 government started 3 pilot programs on precision medicine lead by the Tartu University hospital which means that the precision medicine is moving into real clinical environment, outside from the research setting.  

Prior Service to ASHG: Member, 1995-present; as President of the European Society of Human Genetics in 2005-2006, we always made sure to have close contacts with the ASHG; Abstract submitter and presenter.

Kelly E. Ormond, MS, CGC, LGC

Professor, Department of Genetics and Stanford Center for Biomedical Ethics, Stanford University School of Medicine, 2014-present; Co-Director, MS, Human Genetics and Genetic Counseling, Stanford University.

Education: BA, Biology and Psychology, Bucknell University, Lewisburg, PA, 1992; MS Genetic Counseling, Northwestern University, Chicago IL, 1994; Certified by American Board of Genetic Counseling, 1996; Fellow, MacLean Center for Clinical Medical Ethics, University of Chicago, Chicago, IL, 2000-2001.

Career summary prior to present position: Prenatal, Pediatric, Adult and Teratology Genetic Counselor, University of Vermont College of Medicine, 1994-1997; Instructor, Department of Pediatrics (1997); Prenatal, Teratology and Adult Neurology Genetic Counselor, Northwestern University Medical School, 1997-2007; Instructor (1999-2000) and Assistant Professor (2000-20002), Department of Obstetrics and Gynecology; Assistant Professor (2002-2005) and Associate Professor (2005-2007), Center for Genetic Medicine; Associate Professor, Medical Humanities and Bioethics, 2006-2007; Assistant Director, Graduate Program in Genetic Counseling, 1998-1999; Director, Graduate Program in Genetic Counseling, 1999-2007; Associate Professor (2007-2014) and Professor (2014-present), Department of Genetics and Stanford Center for Biomedical Ethics, Stanford University School of Medicine;  Founding Director (2007-2016) and Co-Director (2016-present), MS in Human Genetics and Genetic Counseling; Licensed genetic Counselor, California, 2011-present.

Honors and Awards:  President, National Society of Genetic Counseling, 2004-2005; “Strategic Leader” Award, National Society of Genetic Counselors, 2009. 

Government and Public Service: NHGRI External Scientific Panel, IGNITE, 2013-2018; Co-Chair, Member, Steering Committee, Consent and Disclosure of Genetic Testing Results (CADRe) Workgroup of ClinGen, 2015-present; National Society of Genetic Counselors, Annual Education Conference Co-Chair, 2000, Board of Directors, 2001-2007, Education Chair, 2001-2013, President, 2004-2005, Jane Engleberg Memorial Fellowship Advisory Group, 2010-2014, Nominating Committee, 2006, 2016; American Board of Genetic Counseling (Nominating Committee, 2010-2011; Member, Practice Based Competency Task Force, 2011-2013; American College of Medical Genetics, Workgroup on Incidental/Secondary Findings 2012-2013, Workgroup on Secondary Findings in WGS 2014-2015; Association of Genetic Counseling Program Directors, Secretary Treasurer, 2000-2002, Nominating Committee, 2012-2013; Meeting Co-Chair, Transnational Alliance of Genetic Counseling, Barcelona, 2016; Member, Committees in Illinois, 2002-2007, and California, 2007-2010, to achieve implementation of genetic counseling licensure. 

Editorial Boards (alphabetical order): Journal of Community Genetics.

Research Interests: Clinical incorporation of new genetic technologies, including relevant models of genetic counseling practice; informed consent and disclosure of genetic testing results; the interface between genetic counseling, ethics and disability studies; the international role of genetic counselors and diversifying the profession.

Prior Service to ASHG: Member since 1992; Member, Social Issues Committee, 2011-2017, Chair, Social Issues Committee, 2015-2016; Member, Program Committee, 2014-2016; Member, Pediatric and Genetic and Genomic Testing Workgroup, 2013-2015; Co-Chair, Workgroup on the Ethical Aspects of Germline Gene Editing, 2015-2017; various roles as abstract reviewer, session moderator and student-mentor lunch attendee, 2002-present.

 


Susan A. Slaugenhaupt, PhD

Scientific Director, Massachusetts General Hospital Research Institute, 2014-present; Professor of Neurology (Genetics), Harvard Medical School, 2013-present; Geneticist, Department of Neurology, Massachusetts General Hospital, 2013-present; Investigator, MGH Center for Genomic Medicine, 2005-present.

Education: BS, Biology, Eckerd College, St. Petersburg, FL, 1985; MS, Human Genetics, University of Pittsburgh, 1988; PhD, Human Genetics, University of Pittsburgh (Aravinda Chakravarti), 1991; Research Fellow, Molecular Neurogenetics, Massachusetts General Hospital/Harvard Medical School (Jim Gusella), 1991-1995.

Career summary prior to current position: Instructor, Neurology, Massachusetts General Hospital (MGH)/Harvard Medical School (HMS), 1995-2000; Assistant Professor, Neurology (Genetics), MGH/HMS, 2000-2006; Associate Professor, Neurology (Genetics), MGH/HMS, 2006-2012.

Honors and Awards: Travel Award, Seventh International Congress of Human Genetics, Berlin, Germany, 1986; Golden Family Foundation Fellowship, Harvard Medical School, 1999; William H. Kadel Medal for Outstanding Career Achievement, Eckerd College Alumni Association, 2005; Elizabeth Riley and Dan E. Smith MGH Research Scholar Award, Massachusetts General Hospital, 2013; Phi Beta Kappa Alumni Inductee, Eckerd College, 2014;  Carlos F. Barbas III for Exceptional Career Achievement in Scientific Research, Eckerd College, 2015; Top Ten Women to Watch in Science and Technology, Boston Business Journal, 2016; Distinguished Alumni Research Award, University of Pittsburgh, 2016; Javits Neuroscience Investigator Award, NINDS, NIH, 2016.

Government and Public Service: Scientific Advisory Board, GenPathway, Inc., 1999-2006; Medical Advisory Board, ML4 Foundation, 2006-present; Scientific Advisory Board, Hereditary Neuropathy Foundation, 2008-2011; Deans Council on Science, Eckerd College, 2009-2012; National Advisory Council to the President, Eckerd College, 2010-2013; Scientific Advisory Board, NIGMS Human Genetic Cell Repository, Coriell Institute, 2010-2012, Chair, 2012-2014; Co-Director, Genetics and Genomics Unit, MGH Clinical Research Program, 2005-2014; Course Director, Genetics in Medicine: From Bench to Bedside, Harvard Medical School, 2006-2014;  Director, CGM Undergraduate Neurogenetics Training Program (PI, NIH R25), 2010-present; Co-Director, US Scientific Director, MITRAL Translatlantic Network of Excellence, Fondation Leducq, 2008-2013; Chair, Human Genetics and Genomics Gordon Research Conference, 2011; Partners Healthcare Biobank at MGH, 2012-present; Board of Trustees, Eckerd College, 2013-present;  Numerous ad hoc review panels for NIH (BDCN, GHD, GTIE, GGG, Distinguished Editor Panel Genetics and Genomics), Scientific Advisory Board, Dysautonomia Foundation, Inc., 2015-present; Therapeutic Approaches to Genetic Diseases (TAG) Study Section, Member 2013-2015, Chair 2015-2017

Research Interests: Human Genetics, Gene Mapping and Cloning; Therapeutic Development for Rare Neurologic Disease; Mucolipidosis Type IV; Familial Dysautonomia; RNA Splicing Disorders; Small Molecule Drug Development for RNA Splicing; Genetics of Mitral Valve Prolapse.

Prior Service to ASHG: Associate Editor, American Journal of Human Genetics, 2009-2012; Chair and Organizer, The Spliceosome and Human Disease Invited Session, ASHG Annual Meeting 2005; ASHG Meeting Attendee, 1986-2016 (except 1997 and 1999); Awards Committee, 2008-2010; ASHG Trainee Awards Reviewer, 2008-2015.

 

Early Career Director (vote for one) (listed alphabetically by last name)

Yvonne Bombard, PhD

Scientist, Li Ka Shing Knowledge Institute, 2013-present; Assistant Professor, Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, 2013-present; Investigator, Toronto Health Economics and Technology Collaborative, University of Toronto, 2013-present; Lead, Public Engagement & Social Values Program, The Canadian Centre for Applied Research in Cancer Control, 2015-present; Chair, Social Issues Committee, American Society of Human Genetics (second term), 2017-present.

Education: BSc, Biology, McGill University, Montreal, Quebec, 1998-2002; PhD, Interdisciplinary Studies in Medical Genetics, Genetic Counseling and Bioethics, University of British Columbia, Vancouver, British Columbia, 2003-2008; Fellow, Health Technology Assessment, Universities of Toronto and Montreal, Ontario/Montreal, Quebec, 2008; Postdoctoral Fellowship, Health Services Research, University of Toronto, 2009-2011; Postdoctoral Fellowship, Cancer Genomics, Memorial Sloan Kettering Cancer Center, New York, NY, 2011-2013; Postdoctoral Fellowship, Health Policy, Yale University, New Haven, CT, 2011-2013.

Career summary prior to present position: Visiting Research Scholar, Medical Advisory Secretariat, Ontario Ministry of Health and Long-term Care, 2008; Visiting Fellow, Department of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, 2008; Visiting Fellow, Centre of HumGen International, University of Montreal, 2008; Postdoctoral Fellow, Department of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, 2009-2011; Research Fellow, Center for Cancer Health Policy and Outcomes Clinical Genetics Service, Memorial Sloan Kettering Cancer Center, 2011-2013; Postdoctoral Fellow, Department of Public Health, Division of Health Policy and Administration, Yale University, 2011-2013; Associate, the Canadian Cancer Centre for Applied Research in Cancer Control (ARCC),  2011-2015; Visiting Investigator, Memorial Sloan Kettering Cancer Centre, Clinical Genetics Service, New York, NY, 2013-2016.

Honors and Awards: Presentation Award, University of British Columbia, Child and Family Research Institute, 2007; ‘Brain Star’ Publication Award, Canadian Institutes of Health Research Institute of Neuroscience, 2009; Research Semi-finalist Award, American Society of Human Genetics, 2010; Publication Award, Lap-Chee Tsui (Inaugural), Canadian Institutes of Health Research, Institute of Genetics, 2010; Rising Star Award, Canadian Institutes of Health Research, Institute of Health Services and Policy Research, 2011; Inaugural Maurice McGregor Award, Canadian Agency for Drugs and Technologies in Health, 2014; Science Leadership Program, University of Toronto, 2016.

Government and Public Service: Canadian Coalition for Genetic Fairness Steering Committee, 2008-present; Genetic Testing/Counseling Working Group- European Huntington Disease Network, 2009-present; Ethics Working Group, Health Technology Assessment International, 2009-present; Chair, Discrimination Sub-committee, European Huntington Disease Network Working Group on Genetic Testing /Counseling, 2009-2010; Quality and Innovation Awards Peer Review Panel, Cancer Quality Council of Ontario, 2010; Steering Committee, Personalized Medicine Signature Event, Cancer Quality Council of Ontario, 2010; Patient and Citizen Involvement Working Group, Health Technology Assessment International, 2010; Personalized Medicine Working Group, Cancer Care Ontario, 2010-2011; National Genome Research Advisory Committee, Globe and Mail National News, 2012; Patient Experience Measurement and Performance Committee, Cancer Care Ontario, 2013-2015; Expert Witness, Testimony for the Standing Senate Committee on Human Rights of The Parliament of Canada, 2014, 2016; Ontario Personalized Medicine Network, 2014-present; Peer Review Committee, Canadian Agency for Drugs and Technology, Maurice McGregor Award, 2015-present; Fellowship Peer Review, Canadian Institutes of Health Research, Health Research Training A- PostPhD committee, Canadian Institutes of Health Research, 2015-2017; Maternal-Child Screening Committee, Provincial Council for Maternal and Child Health, 2016-present; Peer Review Committee, Foundation Grant Stage 1, Canadian Institutes of Health Research, Canada, 2016-present; Ontario Genetic Advisory Committee, Health Quality Ontario‘s Ontario Health Technology Advisory Committee, 2016-present; College of Reviewers, Canadian Institutes of Health Research, 2017-present.

Editorial Boards (alphabetical order):  American Journal of Bioethics, American Journal of Public Health, American Journal of Medical Genetics, The BMJ, BMJ Open, Canadian Medical Association Journal, Clinical Genetics, European Journal of Human Genetics, Genetics in Medicine, Genome, Health Expectations, JAMA Pediatrics, Journal the National Comprehensive Cancer Network, Medical Decision Making, Pediatrics, Public Health Genomics, Psycho-oncology, Social Science and Medicine.

Research Interests: Human Genetics and Genomics, ELSI, Health Services and Policy Research, Public Health Genomics, Health Outcomes Research, Economic Evaluation, Health Technology Assessment, Patient and Public Engagement, Genetic Discrimination, Incidental Findings, Cancer Genomics, Cancer Screening, Newborn Screening, Precision Medicine.

Prior Service to ASHG: Member, Social Issues Committee, 2011-2018; Chair-elect, Social Issues Committee, 2013-2014; Member, Pediatric Genetic and Genomic Testing Guidelines Workgroup, 2013-2016; Chair, Social Issues Committee, 2014-2015; Member, CRISPR/Cas9 Genome Editing Guidelines Workgroup, 2015-2017; Chair-elect, Social Issues Committee, 2016-2017; Chair, Duty to Re-contact Guidelines Workgroup, 2017-present; Chair, Social Issues Committee, 2017-present.

 


Neil A. Hanchard, MBBS (Hons.), DPhil

Neil A. Hanchard, MBBS (Hons.), DPhil

Assistant Professor of Molecular and Human Genetics (Tenure-Track), Baylor College of Medicine (BCM), 2013-present; Assistant Professor, USDA/ARS Children’s Nutrition Research Center, BCM, 2013-present; Assistant Professor, Structural and Computational Biology and Molecular Biophysics, BCM, 2014-present; Director, Laboratory for Translational Genomics, BCM, 2015-present; Co-Director, Human Genetics, Graduate School of Biomedical Sciences, BCM, 2014-present. 

Education: MBBS with honors, University of West Indies (UWI), Jamaica, 1999; DPhil, University of Oxford, Oxford, UK, 2004; Clinical Research Fellow, Tropical Medicine Research Institute, UWI, Jamaica 2004-2006; Resident Physician, Department of Pediatric and Adolescent Medicine, Mayo Clinic School of Graduate Medical Education, Rochester, MN, 2006-2009; Resident Physician, Medical Genetics, BCM, 2009-2011.

Career summary prior to present position: Assistant Professor (non-Tenure-Track), Department of Pediatric and Adolescent Medicine, Mayo Clinic, 2008-2009; Assistant Professor (non-Tenure-Track), Department of Molecular and Human Genetics, BCM, Houston, TX, 2011-2013.

Honors and Awards: Jamaica Rhodes Scholarship, 2000; Jamaica Prime Minister’s National Youth Award, 2000; Mayo Brothers Distinguished Fellowship Award, 2008; Fellow, American College of Medical Genetics and Genomics (elected), 2012; Doris Duke Clinical Scientist Development Award, 2013; National Blood Foundation Scientific Research Scholar, 2014; Member, Society for Pediatric Research (elected), 2016.

Government and Public Service: NIH workshop on Genomic Opportunities for Studying Sickle Cell Disease, 2011; Human Heredity and Health in Africa (H3Africa)- Genome Analysis Workgroup, 2014; Chair, Genome Analysis Manuscript and Publications Sub-group, 2015; Sickle Cell Disease Ontology Working Group, 2015; NIH Career Development Panel, 2016; Ad hoc grant reviewer for Action Medical Research UK; Wellcome Trust, UK; South African Medical Research Council; Einstein Foundation (Berlin); Ad hoc scientific reviewer for Annals of Human Genetics, Human Genetics, American Journal of Human Genetics, Annals of African Medicine, Tissue Antigens, PLoS One, British Journal of Hematology; Human Immunology, New England Journal of Medicine; Neurogenetics, Journal of Pediatrics; European Journal of Inflammation, Pediatric Research, American Journal of Clinical Nutrition, Infection Genetics and Evolution, Pediatrics, Childhood Obesity;

Editorial Boards (alphabetical order): Case Reports in Genetics

Research Interests: Human Genetics and Genomics, Genetic Dissection of Complex Disease Traits; Quantitative Genetics; Integrated Omics; Clinical Genetics and Genomics; Genetics of Sickle Cell Disease; Population Genetics in African Population; Signatures of Selection; Childhood Complex Traits; DNA Methylation in Health and Disease.

Prior Service to ASHG: Session Moderator, Copy Number Variants and Disease, 12th International Congress of Human Genetics, Montreal, 2011.

 


Amy L. Stark, PhD

Director, DNA Learning Center, University of Notre Dame, 2014-present; Assistant Special Professional Faculty, Biological Sciences, University of Notre Dame, 2014-present.

Education: BS summa cum laude, Biology and Political Science, Valparaiso University, Valparaiso, IN 2006; PhD, Human Genetics, University of Chicago, Chicago, IL, 2011.

Career summary prior to present position: PhD student, Department of Human Genetics, University of Chicago, Chicago, IL, 2006-2011; Postdoctoral Scholar, Department of Medicine, University of Chicago, Chicago, IL, 2011-2014.

Honors and Awards: Research Like a Champion, Harper Cancer Center Award Mentor, 2017; Flatley Center for Undergraduate Scholarly Engagement Award Mentor, 2015, 2016; ASHG Finalist, Trainee Research Award, 2011; Lindau Fellowship (sponsored by the National Institute of Health), 60th Lindau Nobel Laureate Meeting on Interdisciplinary Science, 2010; Robert Bosch Stiftung Fellowship, 2010; National Science Foundation Graduate Research Fellowship Honorable Mention, 2007, 2008. Joint Steering Committee for Public Policy (since renamed Coalition for Life Sciences) Travel Award, 2007.

Government and Public Service: Ivy Tech Community College- Central Research in Biotechnology Recruitment and Education Advisory Board, 2014-2015; Intel International Science and Engineering Fair Mentor and Judge, 2014-present; Hoosier Science and Engineering Fair Mentor and Judge 2014-present; Chicago Public School Science and Engineer Fair Judge and Special Award Judge, 2012-present; Educurious Genetics Expert, 2012-2014; Illinois Science Council Associate Board, 2014.

Research Interests: Human Genetics and Genomics, Pharmacogenetics and Genomics, Gene Expression and Regulation, Chemotherapy-Induced Gene Expression and Regulation, Tissue Specific Gene Expression and Regulation, Annotating GWAS results, Cancer Genetics, Genetics Literacy and Public Outreach.

Prior Service to ASHG: Training and Development Committee Member, 2010-2016; Chair, Training and Development Committee, 2013-2016; Future of the Annual Meeting Committee Member, 2014.

 


Jennifer K. Wagner, JD, PhD

Assistant Professor, Center for Translational Bioethics and Health Care Policy, Geisinger Health System, 2015-present; Associate Director, Bioethics Research, Geisinger Health System, 2015-present; and Attorney (solo practitioner, PA ID #206275), 2007-present.

Education: PhD, Anthropology, Pennsylvania State University, University Park, PA, 2010; JD, University of North Carolina, Chapel Hill, NC, 2007; International human rights law studies in minority rights and indigenous peoples rights, Irish Centre for Human Rights, National University of Ireland, Galway, Republic of Ireland, Summer Abroad Program, 2006; Graduate studies, Program in Biomedical Sciences (human genetics concentration), University of Michigan 2002-2003; BA, with honors and high distinction, Anthropology, Pennsylvania State University, University Park, PA, 2002.

Career summary prior to present position: Congressional Fellow, American Association for the Advancement of Science (AAAS) Science & Technology Policy Fellowship Program (Office of U.S. Senator Edward J. Markey), 2014-2015; Assistant Professor, Department of Epidemiology and Population Health, Division of Bioethics, Albert Einstein College of Medicine of Yeshiva University, 2014; Research Associate, Center for the Integration of Genetic Healthcare Technologies (Penn CIGHT), University of Pennsylvania, 2012-2014; Post-Doctoral Researcher, Center for the Integration of Genetic Healthcare Technologies (Penn CIGHT), University of Pennsylvania, 2011-2012; Post-Doctoral Associate, Institute for Genome Sciences & Policy (Duke IGSP), Duke University, 2010-2011; Visiting Assistant Professor, Department of Cultural Anthropology, Duke University, 2010-2011.                    

Honors and Awards: Selected for the Pennsylvania Bar Association (PBA) Bar Leadership Institute, 2016-2017; Selected for the AAAS Judicial Branch Fellowship, 2015-2016 (declined to accept position at Geisinger Health System); AAAS Congressional Science and Engineering Fellowship, 2014-2015; William S. Pollitzer Student Travel Award, American Association of Physical Anthropologists, 2010; Illinois Biology and Politics Summer Institute NSF Fellow, 2009; Certificate of Merit for highest grade in Privacy Law, Spring 2007, University of North Carolina School of Law; Student Marshal, Department of Anthropology, Pennsylvania State University, 2002; and Nominee for Pigment Cell Research Young Investigator of the Year Award, 2002.

Government and Public Service: Congressional Fellow, AAAS Science & Technology Policy Fellowship Program (Office of U.S. Senator Edward J. Markey), 2014-2015; Co-Chair, 2015-present, and Member 2012-present, American Association of Physical Anthropologists Ethics Committee; Member, American Association of Anthropological Geneticists Ethics Committee, 2015-present; PA Bar Association Young Lawyers Division Statewide High School Mock Trial Competition, District Level Volunteer Juror (Judge) 2011, 2014-2017; Centre County Bar Association Civics Essay Contest, 6-7th Grade Judge, 2012; Moot Court Judge, Pennsylvania State University-Dickinson School of Law, 2008; American Bar Association member, 2004-present; Pennsylvania Bar Association member, 2007-present; Centre County Bar Association member, 2007-present. 

Editorial Boards (alphabetical order): Genomics Law Report, PeerJ.

Research Interests: Ethical, legal, and social implications of genetic and genomic technologies, including genetic rights as human rights; genetic non-discrimination; data access, sharing, and privacy; racial disparities in biomedical and criminal justice contexts; DNA Ancestry Testing; characterization of participants, specimens, and data in Research; the effects of ancestry and appearance on identity, experiences of discrimination, and implicit biases; personal genomics in sports; DNA identification in law enforcement and immigration; the medicalization of the human genome and its policy implications; governmental oversight of genetics/omics and mobile health technologies; and participant engagement in research.

Prior Service to ASHG: Member, Social Issues Committee, 2016-present; Member, 2008-present; Member, Genetic Ancestry Inference Roundtable Planning Committee (assisting committee chairs Dr. Michael Bamshad and Dr. Charmaine Royal in the planning and conduct of two diverse stakeholder roundtable discussions in Washington, DC in September 2013 and Durham, NC in May 2015), 2011-2015; assisted with updates to the ASHG Code of Ethics, 2017; Judge, ASHG DNA Day Essay, 2011 and 2014-2017.

 

Trainee Director (vote for one) (listed alphabetically by last name)

Mila Mirceta, BSc

PhD Candidate (Year 3), Laboratory of Dr. Christopher E. Pearson, Genetics and Genome Biology, The Hospital for Sick Children & Department of Molecular Genetics, University of Toronto, Toronto, Canada.

Education: BSc with honors, Molecular Biology and Genetics, McMaster University, Hamilton, Canada, 2009-2013; PhD Candidate, Department of Molecular Genetics, University of Toronto, Toronto, Canada, 2014-present.

Career summary prior to present position: Research Student- recipient of Hamilton Health Sciences Research Award (1 of 12 in Canada), Women’s HIV Empowerment through Life Tools for Health, Hamilton Health Sciences Centre, 2009; Undergraduate research project- characterizing telomere dynamics, Lab of Dr. Xu-Dong Zhu, McMaster University, 2012-2013; MSc, Molecular Genetics- 1 co-first author publication (Nucleic Acid Research, 2015), Lab of Dr. C.E. Pearson, Hospital for Sick Children, 2014-2016; PhD, Molecular Genetics- Project: Elucidation of mutational mechanism of expanded DNA repeat of C9orf72 gene associated with ALS/FTD (reclassification from MSc to PhD stream completed May 2016) and middle authorship in Neuron paper (2017), Lab of Dr. C.E. Pearson, Hospital for Sick Children, 2016-present; Visiting Scientist, Lab of Dr. Frank Kooy, Centre for Medical Genetics, University of Antwerp, Belgium, 2016.

Honors and Awards: Second place in Rapid-Fire Platform presentation (competitive selection), ALS Canada Research Forum, 2017; Ontario Graduate Scholarship (OGS), 2016-2018; Trainee Travel Award, Hospital for Sick Children, 2017; SickKids Research Trainee Competition Award Recipient, Hospital for Sick Children, 2015-2016; Dean’s Honor List- Graduated With Distinction, McMaster University, 2013; University Senate Scholarship, McMaster University, 2012; McMaster President’s Entrance Award, McMaster University, 2009; Hamilton Health Sciences Research Award Recipient, 2009.

Government and Public Service: Manuscript peer-reviewer under guidance of Dr. Pearson (Associate Editor at PLoS Genetics, Human Genetics and Journal of Medical Genetics), Hospital for Sick Children, 2014-present; Undergraduate and Graduate student lab mentor (8 students- 2 of whom published), Pearson Lab, Hospital for Sick Children, 2015-present; Executive Secretary and Event Liaison, SickKids Research Institute Staff Engagement Committee, 2015-present; Co-Chair, “The Scientists” Scientific Outreach & Fundraising Team, Walk for Muscular Dystrophy, 2015-present; Program Committee, ADNP-linked Autism Scientific Conference, Amsterdam, Netherlands, 2016; Co-Chair, Genetic and Genome Biology Social Committee, Hospital for Sick Children, 2015-2016; Program Committee, 8th International Conference on Unstable Microsatellites & Human Disease, Costa Rica, 2015; Field Director and Youth Engagement Officer, Hamilton Youth Engagement Initiative, 2011-2014.

Research Interests: Amyotrophic Lateral Sclerosis (ALS), Frontotemporal Dementia (FTD), Human Genetics, Unstable Repeat Sequence Mutations, Treatment of Genetic Disease, Cytogenetics, Molecular Biology. 


Neil A. Hanchard, MBBS (Hons.), DPhil

Zachary S. Nevin, PhD

MSTP Student, 2010-present.

Education: BS with honors, Biological Sciences, Stanford University, Stanford, CA, 2009; PhD, Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, 2017; MD, Case Western Reserve University School of Medicine, Cleveland, OH, in progress (expected 2019).

Career and research summary prior to present position: High School Summer Intern, Genetics and Pediatrics (Lawrence Nogee lab), Johns Hopkins University School of Medicine, Baltimore, MD, 2003-2004; Summer Research Intern, Sidney Kimmel Comprehensive Cancer Center (Steven Gore lab), Johns Hopkins University School of Medicine, Baltimore, MD, 2006; Undergraduate Research Student, Division of Human Gene Therapy (Mark Kay lab), Stanford University School of Medicine, Stanford, CA, 2006-2009; Research Assistant II (Clinical), Center for Autism and Related Disorders, Kennedy Krieger Institute, Baltimore, MD, 2009-2010.

Honors and Awards: Best Poster, Biomedical Graduate Student Symposium, Case Western Reserve University, 2013; Best Poster, Great Lakes Glia Meeting, 2015; Ruth L. Kirschstein NRSA F30, 2015-present; Semifinalist, Charles J. Epstein Trainee Award for Excellence in Human Genetics Research, American Society of Human Genetics, 2016.

Government and Public Service: Teaching Assistant, Genetics 109Q (Prof. Russ Altman), Stanford University, 2009; Representative at Large, Administrative Panel on Biosafety, Stanford University, 2008-2009; Representative at Large, Faculty Council, Case Western Reserve University School of Medicine, 2010-2012; Chair, Pediatrics Interest Group, Case Western Reserve University School of Medicine, 2011; Chair, Wilderness Medicine Interest Group, Case Western Reserve University School of Medicine, 2011; Founder and Chair, Genetics Interest Group, Case Western Reserve University School of Medicine, 2012; President, MSTP Council, Case Western Reserve University School of Medicine, 2012; Genetics Graduate Student Council, Case Western Reserve University School of Medicine, 2012; Graduate Representative, Faculty Senate Committee on Research, Case Western Reserve University, 2016-present.

Editorial Boards (alphabetical order): Stanford Undergraduate Research Journal, Stanford Scientific Magazine.

Research Interests: Human Genetics and Genomics, Rare Genetic Diseases, Neurogenetics, Development and Diseases of the Nervous System, Leukodystrophies, Pelizaeus-Merzbacher Disease, Spinal Muscular Atrophy, Treatment of Genetic Diseases, Therapeutic Genome Editing, Human Induced Pluripotent Stem Cell Models of Disease, Stem Cell-derived Tissue Engineering, Genetics and Pediatrics.

Prior Service to ASHG: DNA Day, School Presentations and Essay Judge, 2013-present.